NDC 0143-9575-01 - Lidocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9575
- Requested NDC
- 0143-9575-01
- Package NDCs from labels
- 0143-9575-01, 0143-9575-10
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-10-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine - A-S Medication Solutions | A-S Medication Solutions | 2025-10-21 | HUMAN PRESCRIPTION DRUG LABEL |
| LIDOCAINE HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2025-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine - Hikma Pharmaceuticals USA Inc. | Hikma Pharmaceuticals USA Inc. | 2025-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9575-01 | Lidocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 6 | |
| 0143-9575-10 | Lidocaine | 10 in 1 PACKAGE | INJECTION, SOLUTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0143-9575 | LIDOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION LIDOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HIKMA PHARMACEUTICALS USA INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20250521_5523fdfe-69fd-49a5-b51f-73e2223d49a9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9575-01 | ML - Milliliter | 0143-9575 | e0e5c666-8931-44d8-b700-5faf7af18880 | 1 | 2017-10-13 |
| 0143-9575-10 | ML - Milliliter | 0143-9575 | 23cc4249-984a-418e-a4b5-e58307ead774 | 1 | 2017-10-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 951862db-3a73-4d25-9d5b-e4111833f43b | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Hydrocortisone Acetate | LIDOCAINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE | Seton Pharmaceuticals | 6aa284d6-0212-4fb5-809d-c721aa6fe2ba | 2024-01-30 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 993bc59e-5e71-bd9e-e053-2a95a90af85c | 2024-01-28 | Warnings, Adverse reactions | V13007Z41A |
| 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 78d8fb0a-bfae-6599-e053-2991aa0a2e03 | 2024-01-28 | Warnings, Adverse reactions | 1010671 V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | c4c16714-6b1f-857e-e053-2a95a90a74e4 | 2024-01-28 | Warnings, Adverse reactions | V13007Z41A |
| XYLOCAINE | XYLOCAINE | HF Acquisition Co LLC, DBA HealthFirst | e3b3b462-8f35-68b8-e053-2995a90a6403 | 2024-01-27 | Warnings, Adverse reactions | 1010033 |
| LACTATED RINGERS | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | a14ca7d9-de30-a303-e053-2a95a90a5304 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | c901016e-9293-79dd-e053-2a95a90a0fda | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e8bc96bc-7876-4906-e053-2a95a90ae6ba | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e39435a3-1f69-78c5-e053-2995a90a7fc3 | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
| 0.5% LIDOCAINE HCl | 0.5% LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e52fe254-8872-35ce-e053-2a95a90a339e | 2024-01-27 | Warnings, Adverse reactions | V13007Z41A |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | e5247ed5-6170-c13f-e053-2a95a90a4101 | 2024-01-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Target Up and Up Pain Relieving Cleansing | BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE | TARGET CORPORATION | 0f964747-be02-c715-e063-6294a90ad91e | 2024-01-25 | Warnings | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 95351883-ec37-f94a-e053-2995a90aa36a | 2024-01-25 | Warnings, Adverse reactions | V13007Z41A |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea | 2024-01-25 | Warnings, Adverse reactions | 451W47IQ8X |
| CIRCULATION HP | ARNICA MONTANA, AURUM METALLICUM, CACTUS GRANDIFLORUS, CALCAREA CARBONICA, LACHESIS MUTUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, SOLIDAGO VIRGAUREA, | Energique, Inc. | 464d208b-3893-4ec6-9868-12ef6807b98d | 2024-01-23 | Warnings | 451W47IQ8X |
| DERMA SCALE HP | ARSENICUM IODATUM, BORAX, GRAPHITES, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PETROLEUM, SEPIA, SULPHUR | Energique, Inc. | 64961787-7e9a-4e6f-98ce-0f51934155cf | 2024-01-23 | Warnings | 451W47IQ8X |
| Burn First Aid | BURN FIRST AID | Dynarex Corporation | 826e08be-dffa-5a27-e053-2a91aa0a8701 | 2024-01-22 | Warnings | V13007Z41A |
| LIDOCAINE HCI | LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 995e68a7-6986-423e-e053-2995a90acd98 | 2024-01-22 | Warnings, Adverse reactions | V13007Z41A |
| XYLOCAINE | XYLOCAINE | HF Acquisition Co LLC, DBA HealthFirst | 0c6c5678-e987-b822-e063-6394a90ac88b | 2024-01-22 | Warnings, Adverse reactions | 1010033 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.